REFERENCES
1. Khidirova L.D., Fedoruk V.A., Vasil’ev K.O. The role of a new coronavirus infection caused by the SARS-CoV-2 virus in the manifestation of multisystem inflammatory syndrome. Profilakticheskaya meditsina [Preventive Medicine]. 2021; 24 (6): 110–5. DOI: https://doi.org/10.17116/profmed202124061110 (in Russian)
2. Hoste L., Van Paemel R., Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr 2021; 180: 2019–34. DOI: https://doi.org/10.1007/s00431-021-03993-5
3. Schultz C.M., Burke L.A., Kent D.A. A systematic review and meta-analysis of the initial literature regarding COVID-19 symptoms in children in the United States. J Pediatr Health Care. 2023; 37 (4): 425–43. DOI: https://doi.org/10.1016/j.pedhc.2023.02.006
4. Ahmed M., Advani S., Moreira A., et al. Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine. 2020; 26: 100527. DOI: https://doi.org/10.1016/j.eclinm.2020.100527
5. Royal College of Paediatrics and Child Health. Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID. URL: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf (date of access May 15, 2020).
6. Kamali Aghdam M., Jafari N., Eftekhari K. Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report. Infect Dis (Lond). 2020; 52 (6): 427–9. DOI: https://doi.org/10.1080/23744235.2020.1747634
7. CDC COVID-19 Response Team. Coronavirus Disease 2019 in children – United States, February 12–April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (14): 422–6. DOI: https://doi.org/10.15585/mmwr.mm6914e4
8. Alqahtani J.S., Oyelade T., Aldhahir A.M., Alghamdi S.M., Almehmadi M., Alqahtani A.S., et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020; 15 (5): e0233147. DOI: https://doi.org/10.1371/journal.pone.0233147
9. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10 223): 497–506. DOI: https://doi.org/10.1056/nejmoa2021756
10. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10 229): 1054–62. DOI: https://doi.org/10.1016/S1473-3099(20)30651-4
11. Jones V.G., Mills M., Suarez D., Hogan C.A., Yeh D., Segal J.B., et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020; 10 (6): 537–40. DOI: https://doi.org/10.1542/hpeds.2020-0123
12. Verdoni L., Mazza A., Gervasoni A., Martelli L., Ruggeri M., Ciuffreda M., et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020; 395 (10 239): 1771–8. DOI: https://doi.org/10.1016/S0140-6736(20)31103-X
13. Jiehao C., Jin X., Daojiong L., Zhi Y., Lei X., Zhenghai Q., et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020; 71 (6): 1547–51. DOI: https://doi.org/10.1093/cid/ciaa198
14. Centers for Disease Control and Prevention Health Alert Network (HAN). Multisystem Inflammatory Syndrome in Children (MIS-C). Associated with Coronavirus Disease 2019 (COVID-19), 2020. URL: https://emergency.cdc.gov/han/2020/han00432.asp (date of access May 15, 2020).
15. World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19 – 11 March 2020. Geneva: WHO, 2020. URL: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (date of access May 01, 2020).
16. Kuznik B.I., Khavinson V.Kh., Lin’kova N.S. СOVID-19: influence on immunity, hemostasis system and possible ways of correction. Uspekhi fiziologicheskikh nauk [Advances in the Physiological Sciences]. 2020; 51 (4): 51–63. DOI: https://doi.org/10.31857/S0301179820040037 (in Russian)
17. Novikova Yu.Yu., Ovsyannikov D.Yu., Glazyrina A.A., Zhdanova O.I., Zvereva N.N., Karpenko M.A., et al. Clinical, laboratory and instrumental characteristics, course and therapy of pediatric multisystem inflammatory syndrome associated with COVID-19. Pediatriya. Zhurnal imeni G.N. Speranskogo [Pediatrics Journal named after G.N. Speransky]. 2020; 99 (6): 73–83. DOI: https://doi.org/10.24110/0031-403X-2020-99-6-73-83 (in Russian)
18. Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020; 383 (4): 334–46. DOI: https://doi.org/10.1056/NEJMoa2021680
19. Dufort E.M., Koumans E.H., Chow E.J., Rosenthal E.M., Muse A., Rowlands J., et al.; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020; 383 (4): 347–58. DOI: https://doi.org/10.1056/NEJMoa2021756
20. Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020; 183 (4): 968–81.e7. DOI: https://doi.org/10.1016/j.cell.2020.09.016
21. Peregoedova V.N., Bogomolova I.K., Babkin A.A., Tereshkov P.P. The content of some cytokines and chemokines in blood serum in children with coronavirus infection. Voprosy prakticheskoy pediatrii [Problems of Practical Pediatrics]. 2022; 17 (2): 16–22. DOI: https://doi.org/10.20953/1817-7646-2022-2-16-22
22. World Health Organization. Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19. URL: https://www.who.int/publications-detail/multisystem- inflammatorysyndrome-in-children-and-adolescents-with-covid-19 (date of access June 01, 2020).
23. Guidelines for the features of clinical manifestations and treatment of a disease caused by a new coronovirus infection (COVID-19) in children. Version 2 (03.07.2020). URL: https://static0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_дети_COVID-19_v2.pdf (in Russian)
24. Obukhova O.O., Ryabichenko T.I., Karpovich G.S., Skosyreva G.A., Kuimova I.V., Voevoda M.I. Features of laboratory parameters in children with multisystem inflammatory syndrome associated with SARS-CoV-2. Sibirskiy nauchniy meditsinskiy zhurnal [Siberian Scientific Medical Journal]. 2022; 42 (5): 61–8. DOI: https://doi.org/10.18699/SSMJ20220508 (in Russian)
25. Lin Z., Shi J.-L., Chen M., Zheng Z.-M., Li M.-Q., Shao J. CCL2: an important cytokine in normal and pathological pregnancies: a review. Front Immunol. 2023; 13: 1053457. DOI: https://doi.org/10.3389/fimmu.2022.1053457
26. Singh S., Anshita D., Ravichandiran V. MCP-1: function, regulation, and involvement in disease. Int Immunopharmacol. 2021; 101 (pt B): 107598. DOI: https://doi.org/10.1016/j.intimp.2021.107598
27. Prosekova E.V., Turyanskaya A.I., Dolgopolov M.S. Interleukin-17 family in atopy and allergic diseases. RMZh [Russian Medical Journal]. 2018; (2): 15–20 (in Russian)
28. Shahrara S., Pickens S.R., Mandelin A.M., Karpus W.J., Huang Q., Kolls J.K., et al. IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J Immunol. 2010; 184 (8): 4479–87. DOI: https://doi.org/10.4049/jimmunol.0901942